Issuer · CIK 0001936258

NAMS — NewAmsterdam Pharma Co N.V.

Recent filings

Mar 10, 2026·Form 4·Sell$829K
NAMS/NewAmsterdam Pharma Co N.V.
LANGE LOUIS G · director
22conviction
Mar 9, 2026·Form 4·Sell$3.2M
NAMS/NewAmsterdam Pharma Co N.V.
Kastelein Johannes Jacob Pieter · Chief Scientific Officer
8conviction

← Back to all filings

NAMS (NewAmsterdam Pharma Co N.V.) — recent insider filings — Form 4 AI